Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P140031/S210

Edwards SAPIEN 3 Transcatheter Heart Valve (9600TFX), Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (9750TFX)

Edwards Lifesciences, LLC · Decision date Oct 28, 2026

MEDTECHLEDGER EXPLANATIONP140031/S210

What did the FDA decide?

This 30-Day Notice for supplement S210 to PMA P140031 records a process change: implementing an alternative supplier of a chemical manufacturing aid. The affected devices are the Edwards SAPIEN 3 Transcatheter Heart Valve (9600TFX) and the Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (9750TFX), both percutaneously delivered aortic valve prostheses under product code NPT.

The notice does not state which chemical manufacturing aid, which manufacturing step, or which supplier is involved. The FDA decision field reads "OK30," but the source does not define that code. This supplement is not a new approval of the valve systems and does not establish safety or effectiveness; it only reports the supplier change.

FDA approval order statement

implementing an alternative supplier of a chemical manufacturing aid
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 28, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P140031/S210
Regulatory pathway
PMA supplement
Product code
NPT
Decision code
OK30
Decision date
Oct 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Aortic valve, prosthesis, percutaneously delivered.

Product code
NPT
FDA device class
3

For the original device and its historical approval scope, see PMA P140031. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P140031 · Original PMA

    SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES

  2. P140031/S209 · Related supplement

    Edwards Crimper (9600LDS23, 9600LDS26, 9600LDS29, 9750CM20, 9750CM23, 9750CM26, 9750CM29)

  3. P140031/S210 received

    Application receipt date recorded by FDA.

  4. P140031/S202 · Related supplement

    Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve

  5. P140031/S210 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P140031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P140031

Explore the linked device profile

Other records with product code NPT

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records